INTRODUCTION
Human blood platelets play critical roles in normal hemostatic processes and pathologic conditions such as thrombosis, vascular remodeling, inflammation, and wound repair. Generated as cytoplasmic buds from precursor bone marrow megakaryocytes, platelets are anucleate and lack nuclear DNA, although they retain megakaryocyte-derived mRNAs (1, 2) . Platelets contain rough endoplasmic reticulum and polyribosomes, and retain the ability for protein biosynthesis from cytoplasmic mRNA (3) . Quiescent platelets generally display minimal translational activity, although newly formed platelets such as those found in patients with immune thrombocytopenic purpura (ITP) synthesize various -granule and membrane glycoproteins including GPIb and GPIIb/IIIa ( IIb 3 ). Furthermore, stimulation of quiescent platelets by agonists such as -thrombin increases protein synthesis of various platelet proteins including Bcl-3 (4) . Like nucleated cells, the rapid translation of preexisting mRNAs may be regulated by integrin ligation to extracellular matrices (5) . In the case of platelets, the primary integrin involved in this process appears to be IIb 3 with cooperative signals mediated by the collagen receptor 2 1 (6,7). Integrin-mediated platelet protein synthesis appears to be regulated at the level of translation initiation involving the eukaryotic initiation factor 4E (eIF4E). Instead of directly influencing eIF4E activity via posttranslational modifications (i.e. phosphorylation), platelet eIF4E activity best correlates with its spatial redistribution to the mRNA-enriched cytoskeleton (8) .
Furthermore, since protein translation is partially inhibited by the immunosuppressant rapamycin, it suggests that adhesion-and/or aggregation-induced outside-in-signaling function to regulate protein synthesis through the mTOR (mammalian target of rapamycin) pathway (6, 8, 9) .
Despite the biological importance of platelets and their intact protein synthetic capabilities, remarkably little is known about platelet mRNAs. Younger platelets contain larger amounts of mRNA with a greater capacity for protein synthesis, as determined using fluorescent nucleic acid dyes such as For personal use only. by on April 14, 2008 . www.bloodjournal.org From thiazole orange (10) . This assay has been used as a quantitative determinant of younger or "reticulated" platelets (RP). Indeed increased reticulated platelets are typically found in patients with conditions associated with rapid platelet turnover such as ITP; typically RP percentages in such patients approach 10% -20% of all platelets, considerably higher than in normal controls (11) .
Interestingly, high RPs have been associated with enhanced thrombotic risk when identified in patients with thrombocytosis (10) , suggesting that quantitatively increased mRNA levels may be associated with the prothrombotic phenotype. Whether this is related to globally altered gene expression profiles, or select changes more evident during situations of rapid platelet turnover remains unknown.
Certainly, technical limitations of this assay limit its utility in defining prothrombotic genotypes (10) (11) (12) , and it cannot identify differentially expressed genes that may be causally implicated in disordered platelet phenotypes.
Towards the goal of defining the molecular anatomy of the platelet genome, we have adapted complementary techniques of microarray and serial analysis of gene expression (SAGE) for genetic profiling of highly purified human blood platelets. Microarray technology represents a "closed" profiling strategy limited by the target genes imprinted onto gene chips. In contrast, SAGE is an "open" architectural system that can be used to identify novel genes, and to quantify differentially expressed mRNAs (13) (14) (15) . The sequence of each tag along with its positional location uniquely identifies the gene from which it is derived, and differentially expressed genes can be identified in a quantitative manner since the tag frequency reflects the mRNA level at the time of cellular harvest and analysis. By utilizing both technologies, we have identified a number of previously uncharacterized genes that appear to be expressed in human platelets, while simultaneously establishing the dominant frequency of mitochondrial-expressed genomes comprising the platelet mRNA pool. These observations provide a panaromic overview of the platelet transcriptome, while additionally providing B. Platelet isolation, purification, and immunodetection. All human subjects provided informed consent for an IRB (Institutional Review Board)-approved protocol completed in conjunction with the General Clinical Research Center at Stony Brook University Hospital. Peripheral blood (20 mL) from healthy volunteers drawn into 2 mL of 4% sodium-citrate (0.4% v/v final concentration) was used to isolate erythrocytes by differential centrifugation (1500 g), or to isolate pure leukocytes by densitygradient centrifugation as previously described (16) . Platelets collected from healthy volunteers by apheresis were used within 24 hours of collection. After addition of 2 mM EDTA, apheresis-derived platelets from a single donor were centrifuged at 140 g for 15 minutes at 25 0 C. To minimize leukocyte contamination, only the upper 9/10 of the platelet-rich plasma (PRP) was used for gel filtration over a BioGel A50M column (1000 mL total volume) equilibrated with HBMT (HEPESbuffered modified Tyrodes buffer: 10 mM HEPES pH 7.4, 150 mM NaCl, 2.5 mM KCl, 0.3 mM Biotec). Purified platelets were concentrated by centrifugation at 1500 g and immediately used for total RNA isolation.
The efficiency of platelet purification was documented at each step by flow cytometry (17) .
Briefly, aliquots containing 2 x 10 6 platelets were incubated with saturating concentrations of FITCconjugated anti-CD41, PE-conjugated anti-glycophorin, and PERCP-conjugated anti-CD45 for 15 minutes in the dark at 25 0 C, washed with phosphate-buffered saline (PBS), and fixed in PBS/1%
formalin. Samples were analyzed using a FACScan flow cytometer (Becton Dickenson) using
CELLQuest software designed to quantify the number of CD45-and glycophorin-positive events in the sample (expressed as the number of events per 100,000 CD41-positive events). For some experiments, fixed platelets were permeabilized with 0.1% Triton-X/PBS for 30 minutes at 25 0 C prior to the addition of primary antibodies, all as previously described (17) .
Platelet protein detection was completed by SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblot analysis as previously described, using the species-specific horseradish peroxidaseconjugated secondary antibody and enhanced chemiluminescence (16 Oligonucleotide primer pairs were generated using Primer3 software (wwwgenome.wi.mit.edu), designed to generate ~200-bp PCR products at the same annealing temperature, and are outlined in Figure 1B . Purified platelet mRNA (4 µg) was used for first strand cDNA synthesis using oligo(dT) and SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA). For real-time RT-PCR analysis, the RT reaction was equally divided among primer pairs and used in a 40-cycle PCR reaction for each target gene using the following cycle: 94°C for 30 seconds, 55 °C for 30 seconds, 72 °C for 1 minute and 71°C for 10 seconds (40 cycles total). mRNA levels were quantified by monitoring real-time fluorimetric intensity of SYBR green I. Relative mRNA abundance was determined from triplicate assays performed in parallel for each primer pair, and calculated using the comparative threshold cycle number ( -Ct method) as previously described (18) .
Gene expression profiles were completed using the ~12,600 probe set HG-U95Av2 gene chip (Affymetrix, Santa Clara, CA). Total cellular RNA (5 µg) was used for cDNA synthesis using SuperScript Choice system (Life Technologies, Rockville, MD) and an oligo(dT) primer containing the T7 polymerase recognition sequence (Primer S1, see Figure 1B ), followed by cDNA purification using D. Serial analysis of gene expression (SAGE) profiles. Platelet SAGE libraries were generated essentially as previously described (13) , modified as outlined in Figure 1A for the use of MmeI as the tagging enzyme (19) . This type IIS restriction enzyme cleaves 20/18 bp past its non-palindromic (TCCRAC) recognition sequence, thereby generating longer tags (21-or 22-mer) than those obtained using BsmFI as the standard tagging enzyme (13-14 bp tags). These longer MmeI-generated tags potentially provide for more definitive "tag-to-gene" identification, and are particularly useful in characterizing expression patterns in the absence of complete genomic sequence data (comprehensive methods detailed in [19] ). Briefly, poly(A) mRNA was isolated from 10 µg of total platelet RNA using the oligo-(dT) S1 primer conjugated to magnetic beads (Dynal Biotech, Lake Success, NY), followed by cDNA synthesis using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA).
The cDNA was then digested with the restriction enzyme NlaIII (anchoring enzyme), ligated to cassette A using T4 DNA ligase, and after the beads were extensively washed, the cDNA was digested with MmeI to release the tags from the beads. After purification, tags were ligated to degenerate cassette B linkers (specifically designed to anneal to the nonuniform MmeI overhangs), and PCRamplified using biotinylated primers S2 and S3 for 30 cycles (95 0 C -30 sec; 58 0 C -30 sec; 72 0 C -30 sec) using Platinum Taq DNA polymerase (Gibco BRL). A fraction (20%) of the pooled PCR products were then subjected to one round of linear amplification using primer pair S2/S3, followed by a second round of 25 amplifications using primer S2 alone (95 0 C -30 sec; 58 0 C -30 sec; 72 0 C -30 sec). Primer S3 was subsequently added for one cycle (95 0 C -2.5 min; 58 0 C -30 sec; 72 0 C -5 min), the latter steps collectively adapted to exclude heteroduplex formation (18) . Unincorporated primers were removed by incubation with 200 U of Escherichia coli exonuclease I for 60 minutes at 37 0 C.
PCR products were then pooled, digested with NlaIII to release tags, and biotinylated linker arms were cleared using streptavidin-coated immunoaffinity magnetic beads (Dynal Biotech, Lake Success, NY).
Tags were concatamerized using 5 U/µl T4 DNA ligase, and products greater than 100 base pairs were isolated by size-fractionatation in low-melting agarose gels. The DNA was purified by GFX spin columns, and the concatamers were cloned into the SphI site of pZero (Invitrogen, Carlsbad, CA).
After transformation into Escherichia coli TOP10 cells, recombinant clones were isolated and sequenced in 96-well microtiter plates using an ABI 377 sequencer and ABI Prism BigDye terminator chemistry (Perkin-Elmer Applied Biosystems, Branchburg, NJ).
E. Bioinformatic analyses.
Functional grouping of genes determined to be present by Affymetrix were extracted to separate files for manual editing or further examination. Finalized data were exported to a relational database for tag quantification and genetic identification (20) .
RESULTS AND DISCUSSION
A. Platelet purification. To ensure that the RNA profiles accurately represented those of circulating blood platelets, a number of complementary methods were implemented to remove contaminating nucleated leukocytes. Purification methods incorporating gel filtration, a 5-micron leukocyte reduction filter, and magnetic CD45-immunodepletion allowed for the cumulative enrichment of highly-purified platelets. The efficacy of this purification method was initially established using peripheral blood platelet-rich plasma as the starting material. The final product contained no more than 3-5 leukocytes per 1 X 10 5 platelets as determined by parallel flow cytometric analysis, representing an ~450-fold reduction of nucleated leukocytes. These results correlated well with molecular evidence for leukocyte-depletion as determined by RT-PCR using both CD45 and T-cell receptor -chain (TCR )
primers (see below). Since the total RNA yield from peripheral blood platelets was insufficient for microarray studies, we adapted the protocol to platelet apheresis donors with nearly identical final purity ( Figure 2 ). The platelet recovery was nearly 65% of the starting material, yielding ~2.3 X 10 11
platelets from an initial apheresis pack containing ~3.6 X 10 11 platelets. The bulk of the losses occurred during the initial centrifugation and filtration steps. The purification protocol was less effective at removing erythrocytes although there were less than 50 glycophorin-positive cells per 1 X 10 5 platelets after the final purification step. Nonetheless, these cells represent unlikely sources for contaminating cellular RNA (see below).
B. Cellular microarray analysis. The purified platelet RNA was sufficient for microarray studies, and was used for cRNA generation and hybridization to the Affymetrix HG-U95Av2 GeneChip. The anatomic profile of platelet RNAs from three healthy male donors was determined using Affymetrix software. Of the 12,599 probe sets imprinted onto the chip, a maximum of 2,147 (17%) transcripts were computationally identified as "present" by the Affymetrix software, 152 (1.2%) were equivocal, and nearly 82% were absent. As a fraction of the total genes present on the chip, the percentage of platelet-expressed genes (15-17%) was generally lower than that obtained from other human cell types in which 30% -50% of genes are "present" as determined by Affymetrix software (J. Schwedes, personal communication). The "limited number" of platelet-expressed transcripts presumably reflects the lack of ongoing gene transcription in the anucleate platelet. Since less than 1% of circulating red blood cells contain residual RNA, it is unlikely that any of these transcripts are erythrocyte-derived, although this was formally addressed by isolating total cellular RNA from 20 mL of whole blood (corresponding to an ~3-log fold excess of erythrocytes than that identified in our final sample). The total cellular yield of RNA from this starting material was ~250 ng, suggesting that less than 1 ng of erythrocyte-derived RNA was present in the purified platelet preparations. Despite this, however, both -and -globin transcripts --along with both the ferritin heavy and light chains --were identified as abundant transcripts (see Table 1 , below). Although the most parsimonious explanation would be residual contaminating reticulocytes, this is not supported by our erythrocyte contamination estimates, and their significance remains unresolved.
As a means of better dissecting the molecular anatomy of the platelet, expressed genes were grouped on the basis of assigned gene annotations, and this analysis was used to provide a panaromic definition of the platelet transcriptome. Of the genes that could be catalogued within assigned "clusters", those involved in metabolism (11%) and receptor/signaling (11%) represented the largest groups. Also evident in these analyses is the relatively large percentage of genes involved in functions unrelated to these key groups (i.e. miscellaneous, 25%), and the overrepresentation of genes with unknown function (32%) as annotated by Affymetrix and RefSeq databases (20) . These results identify a vast array (nearly one-half) of platelet genes (and gene products) that presumably have important, but poorly characterized functions, in platelet and/or megakaryocyte biology.
For
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Although microarray analysis is not truly quantitative, rank-ordering using the mean logintensities from three independent microarray analyses allowed for the categorization of the top platelet transcripts (Table 1 ). Computational analyses demonstrated that only 10 of the top 100 genes were discordant among the three platelet microarrays, although 71/100 genes were discordant between platelet and leukocyte arrays. An inventory of the top 50 platelet genes is listed in Table 1 , which also delineates those found to be highly expressed in peripheral blood leukocytes by parallel microarray experiments with this purified cellular fraction (data not shown). Further analysis of these cell subsets demonstrated that ~25% (n=547) of the total platelet transcripts were platelet-restricted. Furthermore, only 10 of the 50 most-highly expressed genes were found to overlap, confirming the distinct cellular profiles of each transcriptome. Of the 12 overlap genes, 3 corresponded to globin or ferritin chains (again suggesting the presence of contaminating reticulocytes in both purified fractions), and another 4 were involved in actin cytoskeletal reorganization and human leukocyte antigen (HLA) expression, gene products that regulate critical functions in both cell types. Given the importance of cytoskeletal reorganization in downstream platelet activation events, it is not unexpected that components of the actin machinery system would demonstrate prominent transcript expression. Previous estimates suggest that 20-30% of the total platelet proteome is comprised of actin with other components such as actin-binding protein, mysosin and talin accounting for an additional 2-5% of the total protein (1, 21) .
The mRNAs encoding the actin-related machinery are overrepresented in our microarray analysis, with eight such transcripts found among the 50 highest platelet-expressed genes. Interestingly thymosin 4 demonstrated the highest expression pattern. In unstimulated platelets, 30-40% of actin is polymerized as F-actin (21), while the balance of actin monomers (G-actin) are polymerization-inhibited by sequestering proteins such as profilin (100 µM) and thymosin 4 (600 µM) (22) 
expression not only correlates with its known abundance in platelets, but supports the importance of actin inhibitory proteins in maintaining the non-stimulated state of circulating platelets.
C. Platelet SAGE analyses. While these initial studies identified the distribution and relative expression patterns of the genes within the Affymetrix data set, they do not allow for analyses of genes that are unrepresented by these oligonucleotide chips. Unlike "closed" microarray profiling strategies, SAGE is an "open" architectural system that is ideally suited for novel gene and pathway identification. Accordingly, the platelet RNA used for microarray studies was utilized for platelet SAGE. A total of 2033 tags were initially catalogued, of which 1800 (89%) corresponded to mitochondrial-derived genes. These results were quite different from those obtained by microarray analyses, but the discrepancy can be resolved by the non-representation of the mitochondrial genome on the gene chip. The mitochondrial genome is a compact ~16.6 kb sequence encoding 13 genes and two ribosomal subunits (23) . Primary mitochondrial transcripts are polycystronic, and typically contain premature termination or unpredictable splice sites, resulting in multiple polyadenylated transcripts from individual genes (23, 24) . Indeed, the overall distribution of platelet-derived mitochondrial SAGE tags is quite similar to that found in muscle (24) . All thirteen genes containing NlaIII sites were detected, while neither of the non-NlaIII containing genes were identified (NADH dehydrogenase subunit 4L and ATPase 8). The majority of the tags were from the 16S and 12S ribosomal RNAs --which collectively accounted for 68% of the total mitochondrial tags --with the fewest tags represented by NADH dehydrogenase subunits 3, 5, 6, and cytochrome c oxidase 1 ( Figure   3 ). The NADH dehydrogenase subunit 6 RNA is the only mRNA encoded by the light (L) strand of mitochondrial DNA, and was the least abundantly detected transcript.
The unusually high preponderance of mitochondrial-derived genes is not inconsistent with the known enrichment of these genomes in human platelets (1, 23) , and presumably reflects persistent For personal use only. by on April 14, 2008. www.bloodjournal.org From transcription from the mitochondrial (mt) genome in the absence of nuclear-derived transcripts. This overrepresentation of mtDNA in platelets is considerably greater than that of its closest cell-type (skeletal muscle), in which mt-genomes represent ~20-25% of all SAGE tags (24) . Interestingly, the energy metabolism of platelets is not dissimilar from that of skeletal muscle, both cell types actively utilizing glycolysis and large amounts of glycogen for ATP generation (25) . Like muscle, platelets are metabolically adapted to rapidly expend large amounts of energy required for aggregation, granule release, and clot retraction. Similar to the situation in all eukaryotic cells, platelet mitochondria represent the primary source of ATP, which is generated from oxidative phosphorylation reactions occurring within these organelles. Mitochondria are also responsible for most of the toxic reactive oxygen species generated as by-products of oxidative phosphorylation, and are central regulators of the apoptotic process in other cellular types. The mtDNA encodes polypeptides found within four of the five multifunctional complexes that regulate oxidative phosphorylation within the platelet mitochondria (26) . Whether the continued generation of these polypeptides has a role in platelet energy metabolism and/or the apoptotic mechanisms regulating platelet survival remains speculative, although not inconsistent with our observations.
D. Comparative analysis of SAGE and microarray transcript abundance. Complete SAGE
libraries require the sequencing of up to 30,000 tags for an exhaustive cataloguing of individual mRNAs, especially those with limited copy numbers (13, 27) . Given the preponderance of mt-derived transcripts, comparable sampling would have required sequence analysis of nearly 300,000 SAGE tags, an inordinate number for comprehensive analysis of the platelet transcriptome. For platelets, alternative methodologies incorporating subtractive SAGE will be required for more comprehensive transcript profiling (28) . Our initial sampling of non-mitochondrial genes remains informative, however, and entirely consistent with the results of platelet microarray studies. As shown in Table 2 , Given the small number of non-mitochondrail SAGE tags available for analysis (n = 233), limited conclusions can be drawn using traditional (non-subtraction) platelet SAGE libraries as presented here. Overall, a total of 126 unique tags were identified, the majority of which (94) were represented only once. Of the total unique tags, nearly one-half represented novel genes not present on the Affymetrix U95Av2 GeneChip. Of the genes with unique tags identified more than once, there was excellent concordance with microarray expression analysis, with nearly all of the SAGE tags in Table 2 corresponding to platelet top 75 microarray transcripts. The platelet factor (PF) 4 variant represents a single aberration since this was rank-ordered ~350 by microarray, although its SAGE tag frequency was identical to that of the predominant PF4 transcript. The lack of extensive nonFor personal use only. by on April 14, 2008. www.bloodjournal.org From mitochondrial SAGE sampling precludes any further extrapolations from this apparent aberration. Of note, a subset of these tags had long poly(A) tracts, although they all corresponded to genes identified in the RefSeq database (20) . We cannot exclude the possibility of a SAGE artifact for this small subset of tags (~2% representing 46/2033 tags), although the authenticity of the vast majority of tags (~98%) clearly validates the methodology. These tags are most likely explained by the unique biology of the platelet (i.e. mRNA decay in the absence of de novo transcription), or to mRNA degradation occurring during the extensive purification methods. In summary, even with a remarkably limited sampling, the power of this approach in gene identification of relatively abundant and less abundant transcripts is evident. It is clear, however, given the unique molecular anatomy of the platelet (i.e. abundance of mitochondrial transcripts), that SAGE adaptations will be required for more comprehensive genetic profiling (28) .
E. Protein immunoanalysis of platelet clusterin and neurogranin.
While the majority of "mostabundant" transcripts would conform to a priori predictions for platelet-expressed mRNAs, a number of transcripts were identified that had been poorly characterized in human platelets. To further establish the authenticity of highly expressed transcripts such as clusterin and neurogranin, confirmatory protein analyses were completed. As shown in Figure 4 , both proteins were clearly detected in purified platelet lysates; furthermore, their cellular platelet distributions conformed to those predicted based on previously proposed functions. Note for example that clusterin --functionally characterized as a complement lysis inhibitor able to block the terminal complement reaction -is primarily expressed on the extracellular platelet membrane (29). Given the importance of complement activation in platelet destruction, the prominent expression of cell-surface clusterin might suggest a role for this protein in normal and pathologic events regulating platelet survival. Interestingly, a clusterin-deficient knockout mouse has been generated that demonstrates enhanced cardiac dysfunction substrate that can also be modified by nitric oxide and other oxidants to form intramolecular disulfide bonds. Both its phosphorylation and oxidation state attenuate its binding affinity for calmodulin (32).
In stimulated platelets, PKC generation is linked to various activation pathways such as calciumregulated kinases, mitogen-activated protein (MAP) kinases, and receptor tyrosine kinases (1). Thus, these observations suggest that platelet neurogranin may function as a previously unidentified component of a PKC-dependent activation pathway coupled to one (or more) of these effector proteins.
F. Conclusions. These data provide documentation for a unique platelet mRNA profile that may provide a tool for analyzing platelet molecular networks. Nonetheless, the molecular analysis of the platelet transcriptome may be confounded by the constant decay of mRNAs in the absence of new gene transcription, a situation that may, for example, limit the identification of low-abundance transcripts.
Similarly, since the circulating platelet pool contains a mixed population of variably-aged platelets, a "static" mRNA profile represents an average of this heterogeneous blood pool. Despite these potential limitations, the combination of genomic and proteomic technologies are likely to provide powerful tools for the global analysis of platelet function. Current strategies for cataloguing "whole cellular 3 Leukocyte expression was determined by microarray analysis using purified peripheral blood leukocytes, followed by construction of rank-intensity plots for comparison to platelet top 50 transcripts (38). Top leukocyte-derived transcripts identified within the ranked top 50 platelet transcripts are depicted by a (+) present, or (-) absent. 2 Refers to the RefSeq accession number (20) . Note that this number does not necessarily correspond to the accession number provided by Affymetrix software annotations (Table 1) 3 Presence (P) or Absence (A) is based on results from three distinct platelet microarray experiments. Capitalized "P" designates a gene that is in the top 50 on all three microarray experiments, while small "p" designates those transcripts not in the top 50. Two of the genes ( 2-microglobulin and -thromboglobulin) are represented by three and two probe sets, respectively on the HG-U95Av2 gene chip; for 2-M, all three probe sets were in the top 50 genes, whereas for thymosin 4 one of two was in the top 50 for all experiments (the other probe set was in the top 75 for all experiments). N/A -Oligonucleotide not present on Affymetrix HGU95Av2 gene chip 
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